Cargando…
Hydroxypyridinone-Diamine Hybrids as Potential Neuroprotective Agents in the PC12 Cell-Line Model of Alzheimer’s Disease
There is an urgent need to propose effective treatments for Alzheimer’s disease (AD). Although the origin of the disease is poorly understood, several therapeutic options have been proposed. The new therapeutic approaches targeting biometal-mediated neurodegenerative pathways appear to be interestin...
Autores principales: | Lohou, Elodie, Sasaki, N. André, Boullier, Agnès, Duplantier, Marine, Sonnet, Pascal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958408/ https://www.ncbi.nlm.nih.gov/pubmed/31717866 http://dx.doi.org/10.3390/ph12040162 |
Ejemplares similares
-
Quorum Sensing Inhibitors to Quench P. aeruginosa Pathogenicity
por: Duplantier, Marine, et al.
Publicado: (2021) -
Discovery of benzamide-hydroxypyridinone hybrids as potent multi-targeting agents for the treatment of Alzheimer's disease
por: Jiang, Xiaoying, et al.
Publicado: (2021) -
Functionality study of chalcone-hydroxypyridinone hybrids as tyrosinase inhibitors and influence on anti-tyrosinase activity
por: Singh, L. Ravithej, et al.
Publicado: (2020) -
Optimisation of a PC12 cell-based in vitro stroke model for screening neuroprotective agents
por: Chua, PinFen, et al.
Publicado: (2021) -
A 3,2-Hydroxypyridinone-based Decorporation Agent that Removes Uranium from Bones In Vivo
por: Wang, Xiaomei, et al.
Publicado: (2019)